Readers will open a news feature about recent clinical research probing whether popular GLP-1 weight-loss drugs might influence biological aging markers. The piece invites curious readers to learn what kinds of aging measures scientists are now using and why researchers find these signals noteworthy.
Key Takeaways
- Randomized trial reported semaglutide slowed epigenetic aging measured by the PCGrimAge clock
- Pilot study found 42% of participants showed slowed biological aging by DunedinPACE after semaglutide treatment
- Nearly 49% of pilot study participants exhibited longer telomere estimates and improved walking speed after treatment